RATINGS CHANGES

AmerisourceBergen (ABC - Get Report) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: ABC.

DSW (DSW) was downgraded to hold at Jefferies. $25 price target. The company has limited earnings upside potential, Jefferies said. 

Dexcom (DXCM - Get Report) was downgraded to equal-weight from overweight at Morgan Stanley. $66 price target. Libre risk is not yet factored into the stock, Morgan Stanley said. 

Medtronic (MDT - Get Report) was downgraded to equal-weight from overweight at Morgan Stanley. $77 price target. The company is facing growth challenges, Morgan Stanley said. 

Methanex (MEOH - Get Report) was downgraded to market perform from outperform at Raymond James. $48 price target. Methanol prices will likely fade soon, Raymond James said. 

Nokia (NOK - Get Report) was downgraded to neutral from outperform at Oppenheimer. The company is seeing muted spending trends, Oppenheimer said. 

Paccar (PCAR - Get Report) was downgraded to neutral from outperform at Baird. $62 price target. The valuation is less attractive, as the stock outperformed the broader market by 25% last year, Baird said. 

Valmont Industries (VMI - Get Report) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: VMI.

Verizon (VZ - Get Report) was upgraded to buy from neutral at Citigroup. $60 price target. The company is expanding its addressable market, Citi said. 

Xilinx (XLNX - Get Report) was downgraded to reduce from neutral at Nomura. $45 price target. The valuation is less attractive, as the company is valued at 26x expected earnings, Nomura said. 

Xerox (XRX - Get Report) was upgraded to outperform from neutral at Credit Suisse. $8 price target. Cost-savings should drive margin expansion, following the business spin, Credit Suisse said. 

This article was written by a staff member of TheStreet.